| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,095 |
16,613 |
$1.15M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,624 |
5,773 |
$223K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,668 |
2,561 |
$190K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,131 |
4,342 |
$155K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,560 |
1,323 |
$113K |
| 87634 |
|
1,517 |
1,075 |
$63K |
| 71046 |
Radiologic examination, chest; 2 views |
2,977 |
2,362 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29,525 |
8,852 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,189 |
905 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,386 |
1,973 |
$24K |
| 99215 |
Prolong outpt/office vis |
484 |
379 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,558 |
3,572 |
$21K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
131 |
65 |
$20K |
| 82607 |
|
1,554 |
1,284 |
$14K |
| 70220 |
|
713 |
607 |
$13K |
| 72100 |
|
529 |
446 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
7,861 |
6,052 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,108 |
4,191 |
$7K |
| 84402 |
|
417 |
322 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,595 |
5,555 |
$7K |
| 84403 |
|
417 |
315 |
$6K |
| 99406 |
|
1,050 |
633 |
$6K |
| 82962 |
|
4,184 |
2,749 |
$6K |
| 84439 |
|
905 |
766 |
$5K |
| 93000 |
|
384 |
345 |
$3K |
| 82670 |
|
190 |
153 |
$3K |
| 74018 |
|
238 |
201 |
$3K |
| 72040 |
|
145 |
135 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
194 |
168 |
$2K |
| 99205 |
Prolong outpt/office vis |
26 |
19 |
$2K |
| 81002 |
|
932 |
735 |
$1K |
| 84153 |
|
184 |
138 |
$1K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
18 |
13 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26 |
23 |
$872.27 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
49 |
45 |
$588.00 |
| 86308 |
|
145 |
120 |
$565.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,508 |
2,648 |
$420.04 |
| 90756 |
|
35 |
28 |
$389.06 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$388.45 |
| 90688 |
|
27 |
27 |
$285.44 |
| 90674 |
|
16 |
14 |
$269.46 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
1,362 |
784 |
$260.28 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,773 |
1,164 |
$238.59 |
| 90686 |
|
19 |
18 |
$209.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
14 |
$170.69 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
483 |
308 |
$162.86 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
19 |
15 |
$156.28 |
| 86318 |
|
14 |
14 |
$154.56 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
322 |
220 |
$147.10 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
152 |
91 |
$70.25 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
299 |
200 |
$63.14 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
182 |
111 |
$52.32 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
3,351 |
2,105 |
$34.50 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
91 |
68 |
$33.91 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
164 |
100 |
$17.78 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
29 |
17 |
$0.44 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
164 |
93 |
$0.00 |
| J1000 |
Injection, depo-estradiol cypionate, up to 5 mg |
165 |
123 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
125 |
53 |
$0.00 |
| 90653 |
|
14 |
14 |
$0.00 |
| 3078F |
|
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$0.00 |
| 3074F |
|
18 |
17 |
$0.00 |